Unfortunately no news or hints regarding 3D printing involvement or injection moulding manufacture. Also despite the company predictions of rising revenue and falling costs, the quarterly reveals falling customer receipts (- 52%) and rising research costs (+9%) and rising staff costs (+6.5%) as well as another CR due before end of CY24.
Enough for me to leave AVR on the watch list, waiting for a more suitable entry, until there's some news or trading improves.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-9
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.07 |
Change
-0.030(0.14%) |
Mkt cap ! $404.7M | |||
| Open | High | Low | Value | Volume |
| $21.25 | $21.25 | $20.67 | $156.2K | 7.497K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 193 | $20.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.07 | 3571 | 1 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.93 |
Change
-0.030 ( 0.66 %) |
||||
| Open | High | Low | Volume | ||
| $20.80 | $21.05 | $20.80 | 96 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| AVR (ASX) Chart |